Markus Bickel

2.9k total citations
73 papers, 1.9k citations indexed

About

Markus Bickel is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Markus Bickel has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 36 papers in Virology and 30 papers in Epidemiology. Recurrent topics in Markus Bickel's work include HIV/AIDS drug development and treatment (38 papers), HIV Research and Treatment (36 papers) and HIV/AIDS Research and Interventions (25 papers). Markus Bickel is often cited by papers focused on HIV/AIDS drug development and treatment (38 papers), HIV Research and Treatment (36 papers) and HIV/AIDS Research and Interventions (25 papers). Markus Bickel collaborates with scholars based in Germany, United States and United Kingdom. Markus Bickel's co-authors include Schlomo Staszewski, Christoph Stephan, Jens Lundgren, H.-R. Brodt, Peter Reiss, Volker Rickerts, Annette Haberl, Hans Wilhelm Doerr, Peter Bacchetti and W. Schlote and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Markus Bickel

68 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Markus Bickel 1.1k 691 657 638 154 73 1.9k
Vincenzo Colangeli 1.2k 1.1× 436 0.6× 822 1.3× 775 1.2× 93 0.6× 81 2.0k
Joaquín Portilla 1.4k 1.2× 753 1.1× 940 1.4× 564 0.9× 280 1.8× 160 2.3k
Antonio Chirianni 553 0.5× 292 0.4× 429 0.7× 444 0.7× 170 1.1× 70 1.1k
Eva Wolf 867 0.8× 803 1.2× 480 0.7× 297 0.5× 452 2.9× 108 2.3k
Tiziana Quirino 841 0.8× 331 0.5× 493 0.8× 557 0.9× 100 0.6× 60 1.5k
Yang Han 1.2k 1.1× 376 0.5× 487 0.7× 273 0.4× 160 1.0× 104 1.8k
Enric Pedrol 907 0.8× 484 0.7× 772 1.2× 646 1.0× 97 0.6× 91 1.8k
Julian Falutz 857 0.8× 536 0.8× 679 1.0× 1.3k 2.1× 65 0.4× 79 2.2k
Alessandro Cozzi‐Lepri 1.3k 1.2× 513 0.7× 1.1k 1.6× 437 0.7× 105 0.7× 82 2.0k
Giuliano Rizzardini 800 0.7× 341 0.5× 539 0.8× 286 0.4× 99 0.6× 39 1.3k

Countries citing papers authored by Markus Bickel

Since Specialization
Citations

This map shows the geographic impact of Markus Bickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Bickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Bickel more than expected).

Fields of papers citing papers by Markus Bickel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Bickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Bickel. The network helps show where Markus Bickel may publish in the future.

Co-authorship network of co-authors of Markus Bickel

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Bickel. A scholar is included among the top collaborators of Markus Bickel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Bickel. Markus Bickel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wichelhaus, Thomas A., Timo Wolf, Benjamin Marx, et al.. (2025). Delayed CD4 cell recovery in HIV-associated disseminated nontuberculous mycobacterial disease: A case-control study. International Journal of Infectious Diseases. 160. 108037–108037.
2.
Cadar, Dániel, Martin Gabriel, Gundolf Schüttfort, et al.. (2024). Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir. International Journal of Infectious Diseases. 143. 107017–107017.
3.
Krings, Amrei, Christian Kollan, Daniel Schmidt, et al.. (2024). Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999–2023). Infection. 53(3). 1013–1028.
4.
Graf, Christiana, Lara Fuhrmann, Thomas A. Lutz, et al.. (2023). Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years. JHEP Reports. 5(7). 100701–100701. 2 indexed citations
5.
Akmatov, Manas K., Christian Kollan, Daniel Schmidt, et al.. (2023). Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany. HIV Medicine. 25(4). 498–503.
6.
Koppe, Uwe, Daniel Schmidt, Amrei Krings, et al.. (2023). Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study. Archives of Public Health. 81(1). 159–159. 2 indexed citations
7.
Baldauf, Hanna‐Mari, Stefan Stein, Gerrit Kann, et al.. (2022). HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo. Cells. 11(19). 2968–2968. 11 indexed citations
8.
Hentrich, Marcus, Mark Bower, Gedske Daugaard, et al.. (2021). Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. Cancer. 128(2). 260–268. 2 indexed citations
9.
Crowell, Trevor A., Haoyu Qian, Carsten Tiemann, et al.. (2021). Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort. AIDS Research and Therapy. 18(1). 52–52. 3 indexed citations
10.
Kann, Gerrit, Nils Wetzstein, Gundolf Schuettfort, et al.. (2021). Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation. Journal of Infection. 83(3). 347–353. 4 indexed citations
11.
Bickel, Markus, Christian Hoffmann, Eva Wolf, et al.. (2020). High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection. 48(3). 453–461. 10 indexed citations
12.
Bickel, Markus, Imke Wieters, Hans Wilhelm Doerr, et al.. (2013). Immune Response after a Single Dose of the 2010/11 Trivalent, Seasonal Influenza Vaccine in HIV-1–Infected Patients and Healthy Controls. HIV Clinical Trials. 14(4). 175–184. 10 indexed citations
13.
Perri, Giovanni Di, Bruce Green, Glynn Morrish, et al.. (2013). Pharmacokinetics and Pharmacodynamics of Etravirine 400 mg Once Daily in Treatment-Naïve Patients. HIV Clinical Trials. 14(3). 92–98. 5 indexed citations
14.
Rabenau, Holger F., et al.. (2013). The Management of Needlestick Injuries. Deutsches Ärzteblatt international. 110(5). 61–7. 45 indexed citations
15.
Bickel, Markus, Imke Wieters, Pavel Khaykin, et al.. (2010). Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS. 24(9). F31–F35. 57 indexed citations
16.
Stephan, Christoph, et al.. (2008). Vergleichbare Antibiotikaresistenz von Pneumokokkenisolaten HIV-positiver und -negativer Patienten*. Medizinische Klinik. 103(2). 69–74. 2 indexed citations
17.
18.
Stephan, Christoph, Annemarie Berger, Amina Carlebach, et al.. (2005). Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. Journal of Antimicrobial Chemotherapy. 56(6). 1087–1093. 30 indexed citations
19.
Wolf, Timo, et al.. (2003). A Case of Severe CMV-colitis in an HIV Positive Patient Despite Moderate Immunodeficiency. Scandinavian Journal of Infectious Diseases. 35(11-12). 905–907. 7 indexed citations
20.
Rickerts, Volker, et al.. (2000). A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV‐1‐infected patient. HIV Medicine. 1(3). 164–165. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Colangeli Breakdown of academic impact, for papers by Joaquín Portilla Breakdown of academic impact, for papers by Antonio Chirianni Breakdown of academic impact, for papers by Eva Wolf Breakdown of academic impact, for papers by Tiziana Quirino Breakdown of academic impact, for papers by Yang Han Breakdown of academic impact, for papers by Enric Pedrol Breakdown of academic impact, for papers by Julian Falutz Breakdown of academic impact, for papers by Alessandro Cozzi‐Lepri Breakdown of academic impact, for papers by Giuliano Rizzardini
Rankless by CCL
2026